Screening for cervical cancer: Should we test for infection with high-risk HPV?

CMAJ. Canadian Medical Association Journal

Volumn 163, Issue 5, 2000, Pages 535-538

  Meijer, C J L M ^a   Snijders, P J F ^a   Van Den Brule, A J C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER SCREENING; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HUMAN; INFECTION RATE; INFECTION RISK; NOTE; PAPANICOLAOU TEST; PREVALENCE; SEXUAL BEHAVIOR; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

EID: 0034609373     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (28)

1. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
2. PCR-based high risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears
3. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
4. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study
5. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia
6. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia
7. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective
8. Predicting mortality from cervical cancer after negative smear test results
9. Risk factors for cervical cancer in Thailand: A case-control study
10. The causes of cervical cancer in the Philippines: A case-control study
11. Utility of liquid-based cytology for cervical carcinoma screening: Results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma
12. 'ASCUS, rule out HSIL': Cytologic features, histologic correlates, and human papillomavirus detection
13. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicolaou results
14. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL
15. Prediction of recurrent and residual cervical dysplasia by human papillomavirus detection among patients with abnormal cytology
16. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri
17. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens
18. Genital papillomavirus infection after treatment for cervical intraepithelial neoplasia (CIN) III
19. Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: Possible implications for cervical cancer screening
20. Human papillomavirus testing for primary cervical cancer screening
21. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada
22. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent
23. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: The age-related pattern
24. The causal link between human papillomavirus and invasive cervical cancer: A population-based case-control study in Colombia and Spain
25. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial
26. Present evidence in the value of HPV testing for cervical cancer screening: A model-based explanation of the (cost) effectiveness
27. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions
28. Screening for cervical neoplasia by self-assessment for human papillomavirus DNA